Despite recent advances in prevention and treatment — including expanded use of dual-ingredient insecticide-treated nets, seasonal preventive therapy, and WHO-approved malaria vaccines — the burden remains overwhelmingly concentrated in the African region.
According to WHO data, the African region accounted for approximately 94 % of all malaria cases and 95 % of malaria deaths in 2024. Children under five remain the most vulnerable: in Africa, around three-quarters of malaria fatalities occur among this age group.
The burden is particularly acute in a small number of countries. Nigeria, Democratic Republic of the Congo (DR Congo), and Niger together contributed almost half of all malaria deaths on the continent. Nigeria alone accounted for nearly a third of those deaths, underlining the stark concentration of mortality.
The reasons for this resurgence are multiple and alarming. WHO flagged antimalarial drug resistance — including growing resistance to artemisinin derivatives — as a major obstacle. In addition, resistance to the insecticides used in treated nets is undermining one of the core tools of malaria prevention.
External factors are compounding the crisis. Global funding for malaria control remains far below what is needed to sustain — let alone accelerate — progress. In 2024, investments amounted to about US$ 3.9 billion, less than half of the estimated requirement for effective global response. Meanwhile, environmental changes (for example shifts in rainfall and temperature), growing population at risk, and social-economic stresses such as conflict, poverty and limited access to health services are expanding both exposure and vulnerability across many African communities.
The WHO notes that even though the rollout of new prevention tools has helped avert many cases in the past year — including vaccines and improved nets — the increasing trend in cases and deaths suggests the fight against malaria is at a critical juncture.
In short: although remarkable progress was made over the past two decades, the latest data show that malaria remains a deeply entrenched scourge — and Africa bears the overwhelming brunt of that burden. The rising death toll is a sobering reminder that without renewed commitment, sustained funding, and equitable access to prevention and treatment, the goal of malaria elimination remains distant.
]]>Over the course of the outbreak, health officials recorded a total of 64 cases (53 confirmed, 11 probable) and 45 deaths, yielding a high case-fatality rate of around 70%. Among the infections were several healthcare workers, underscoring the risks even to those on the frontline.
The response to the outbreak was rapid and coordinated. The national health authorities, with the backing of the World Health Organization (WHO), mobilized hundreds of health workers and delivered more than 150 tonnes of medical supplies and protective equipment to contain the spread. In addition, an innovative treatment facility — the Infectious Disease Treatment Module (IDTM) — was deployed for the first time in the DRC, enabling safer, more dignified and effective care for patients.
Vaccination also played a critical role: tens of thousands of people — including contacts of confirmed cases and frontline health workers — received Ebola vaccines from global stockpiles, significantly bolstering containment efforts.
While the outbreak is officially declared over, authorities have stressed that vigilance must continue. A 90-day period of enhanced surveillance will be implemented to quickly identify any resurgence. Health experts also called for continued investments in water, sanitation, safe-burial practices, and community engagement to strengthen long-term resilience against future outbreaks.
The declaration marks another milestone in the DRC’s long history of battling Ebola — the 16th outbreak since the virus was first identified there in 1976. It underscores both the fragility of health systems in remote regions and the progress possible through coordinated national and international action.
As the country transitions away from emergency response mode, public health officials emphasize the dual challenge ahead: ensuring surveillance remains strong, while rebuilding trust and services in affected communities — a foundation essential to prevent future outbreaks.
]]>From the start, WHO has moved quickly to mount a multi‑pronged response alongside the DRC Ministry of Health and partners. Key measures include:
Several factors complicate the response:
WHO assesses the public health risk as high nationally, moderate regionally, and low globally, given the containment measures underway. The window for effective intervention is narrow, but with sustained international support, good coordination, and community cooperation, control of the outbreak remains possible.
]]>The index case was a 34-year-old pregnant woman from Boulapé (Bulape), a locality in southern Kasai. She exhibited high fever, vomiting, bloody diarrhea, hemorrhaging, and extreme fatigue. After being admitted on 20 August, she tragically succumbed to multiple organ failure on 25 August.
As of 4 September, there were 28 suspected cases, with 15 deaths reported—a case fatality rate (CFR) of approx. 54%. Among the deceased were four healthcare workers, underscoring the perilous risks faced by medical personnel. The suspected cases span several areas within Bulape health zone (including Bulape Com and Dikolo) and parts of the neighboring Mweka health zone.
Laboratory testing performed at the INRB (National Institute of Biomedical Research) in Kinshasa using GeneXpert and PCR assays confirmed the virus as the Zaire strain of Ebola, recognized as the most virulent form. Genome sequencing suggests this outbreak stems from a new zoonotic spillover event, rather than a resurgence of prior outbreaks.
In response, a Rapid Response Team, backed by the World Health Organization (WHO) and other partners, has been deployed to Kasai to bolster surveillance, case management, infection prevention, and community engagement. Supplies including personal protective equipment (PPE), mobile labs, treatments, and 2,000 doses of the Ervebo vaccine are being mobilized to support containment efforts.
Authorities emphasize proactive measures such as limiting public gatherings, reinforcing hygiene practices, and localized movement restrictions. However, containment is challenged by a fragile healthcare infrastructure, supply shortages, and the lingering impact of regional conflicts.
This outbreak marks another sobering reminder of the DRC’s longstanding battle with Ebola, particularly given the complexities of controlling highly infectious hemorrhagic fevers in regions with limited resources and ongoing instability.
]]>Background & Scale of the Project
Initiated in 2012, Target Malaria focused on deploying gene-drive and sterile male mosquito technologies to disrupt malaria transmission. Burkina Faso became the first African nation to conduct such releases—starting in 2019—with further trials continuing into August 2025. The goal: suppress mosquito populations by interfering with their reproductive capacity.
Reasons for Suspension
A coalition of civil society groups, notably the Coalition for Monitoring Biotechnological Activities in Burkina Faso (CVAB), vehemently criticized the project as “highly controversial, unpredictable, and posing ethical challenges.” Concerns included:
Government Response & Actions Taken
On August 22, 2025, the Ministry of Higher Education, Research and Innovation announced the suspension of Target Malaria’s operations. It ordered facilities containing genetically modified mosquitoes to be sealed, and instructed that all remaining samples be destroyed under a strict protocol.
This move aligns with a broader campaign by Traoré’s military administration to limit foreign influence: earlier in 2025, the government had already revoked operating licenses of 21 international NGOs.
Implications & Future Direction
The suspension underscores a pivotal shift in public health governance—emphasizing national sovereignty and ethical oversight over potentially transformative but experimental global health initiatives. Burkina Faso reaffirmed its commitment to combating malaria through safer, more transparent methods, such as vaccine campaigns and preventive programs.
In short, Burkina Faso’s decision marks a significant milestone: a clearly articulated demand for local control, accountability, and public trust in medical and scientific interventions. It sends a powerful message that breakthrough technology must be balanced with ethical safeguards and community engagement.
]]>The Ministry of Health had warned earlier in the month of dwindling supply levels, which led to the postponement of all non‑urgent surgeries. Medications needed for chronic and critical conditions—including treatment for hypertension, cancer, diabetes, tuberculosis, asthma, and mental and reproductive health—were reportedly running dangerously low. Additional shortages included basic medical supplies such as dressings and sutures.
Two key factors contributed to this crisis:
President Boko responded with decisive action: he secured an emergency allocation of 250 million pula (approximately USD 17–18 million) to procure life-saving medical supplies. To ensure rapid and equitable distribution, he tasked the military with overseeing the supply chain, particularly targeting underserved and rural communities.
An in-depth review exposed glaring inefficiencies and potential corruption within the Central Medical Stores (CMS)—Botswana’s state procurement agency. CMS provided a quote of 705 million pula for a year’s worth of medicines, while an independent emergency task force estimated the same supplies could be procured for less than 80 million pula. The discrepancy points to serious overpricing, mismanagement, and possible graft.
With a population of around 2.5 million, Botswana faces a critical moment: the public health system is under immense pressure, and delays in addressing the procurement and distribution failures could lead to loss of life and further strain on healthcare infrastructure. Progress in Bolivia’s fight against HIV, maternal and child health, and chronic disease management is now at risk. The systemic issues, notably dependency on diamonds and donor aid, expose the need for structural reforms.
President Boko’s emergency measures—financial injection, military-led distribution, and spotlighting corruption—provide an immediate lifeline. Yet, the sustainability of Botswana’s public health system hinges on overhauling procurement systems, diversifying the economy beyond diamonds, and ensuring resilience against future shocks. The emergency highlights how vital institutional accountability and fiscal prudence are to the health of the nation’s people.
]]>As of August 2025, aid agencies report that over 10,000 suspected cholera cases have been identified across several camps, with hundreds of confirmed deaths. The hardest-hit areas include camps in White Nile, Gedaref, and Kassala states, where tens of thousands of displaced people live in makeshift shelters without adequate access to clean drinking water or proper sewage systems. The disease, which causes severe diarrhea and dehydration, can kill within hours if not treated quickly.
Humanitarian organizations on the ground warn that the situation is spiraling out of control. Medical supplies are limited, and health workers are overwhelmed. Many treatment centers have reached capacity, and a lack of funding is hampering the ability of agencies to scale up emergency response efforts. The rainy season has further worsened the situation, contaminating water sources and accelerating the spread of the disease.
Cholera outbreaks are not new in Sudan, but the ongoing conflict between the Sudanese Armed Forces and the Rapid Support Forces (RSF) has severely damaged public health infrastructure, making containment efforts far more difficult. Many health facilities have been destroyed or abandoned, while the insecurity makes it hard for aid convoys to reach the most affected areas. The breakdown in government services has also delayed national-level coordination and response.
Children, the elderly, and people with compromised immune systems are most at risk. Families already suffering from food insecurity and trauma are now forced to watch their loved ones die from a preventable disease. Aid workers are calling for urgent international intervention, including funding for cholera vaccines, clean water delivery, sanitation infrastructure, and support for mobile health units.
The crisis highlights the broader collapse of Sudan’s health and humanitarian systems amid war and displacement. Unless swift action is taken, the cholera outbreak could claim thousands more lives. Aid organizations stress that cholera is entirely preventable and treatable — but only if the world responds in time to the suffering unfolding in Sudan’s forgotten camps.
]]>